{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T05:45:37Z","timestamp":1693892737909},"reference-count":19,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista de Calidad Asistencial"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.cali.2015.01.009","type":"journal-article","created":{"date-parts":[[2015,3,3]],"date-time":"2015-03-03T11:11:24Z","timestamp":1425381084000},"page":"72-78","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Calidad de la prescripci\u00f3n de verapamilo de liberaci\u00f3n convencional en pacientes con hipertensi\u00f3n arterial"],"prefix":"10.1016","volume":"30","author":[{"given":"J.E.","family":"Machado-Alba","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Giraldo-Giraldo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.E.","family":"Machado-Duque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cali.2015.01.009_bib0100","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s11906-013-0340-9","article-title":"High blood pressure: The leading global burden of disease risk factor and the need for worldwide prevention programs","volume":"15","author":"Bromfield","year":"2013","journal-title":"Curr Hypertens Rep."},{"key":"10.1016\/j.cali.2015.01.009_bib0105","unstructured":"Ministerio de Salud y Protecci\u00f3n Social. Encuesta Nacional de Salud, Colombia, 2007 [consultado Ene 2014]. Disponible en: http:\/\/www.minsalud.gov.co\/Documentos%20y%20Publicaciones\/Encuesta%20Nacional.pdf"},{"key":"10.1016\/j.cali.2015.01.009_bib0110","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/jama.2013.284427","article-title":"2014 evidence-based guideline for the management of high blood pressure in adults: Report from the panel members appointed to the Eighth Joint National Committee (JNC 8)","volume":"311","author":"James","year":"2014","journal-title":"JAMA."},{"key":"10.1016\/j.cali.2015.01.009_bib0115","doi-asserted-by":"crossref","first-page":"273","DOI":"10.7705\/biomedica.v24i3.1273","article-title":"Effectiveness of treatments for hypertension in a sample of Colombian patients","volume":"24","author":"Isaza","year":"2004","journal-title":"Biomedica."},{"key":"10.1016\/j.cali.2015.01.009_bib0120","unstructured":"Brunton L, Chabner B, Knollmann B. Goodman & Gilman's the pharmacological basis of therapeutics, 12e. New Haven, USA:McGraw-Hill Education."},{"key":"10.1016\/j.cali.2015.01.009_bib0125","doi-asserted-by":"crossref","first-page":"415","DOI":"10.2165\/00129784-200202060-00006","article-title":"Calcium channel antagonists in the treatment of hypertension","volume":"2","author":"Weber","year":"2002","journal-title":"Am J Cardiovasc Drugs."},{"key":"10.1016\/j.cali.2015.01.009_bib0130","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1001\/jama.1995.03530080036038","article-title":"The risk of myocardial infarction associated with antihypertensive drug therapies","volume":"274","author":"Psaty","year":"1995","journal-title":"JAMA."},{"key":"10.1016\/j.cali.2015.01.009_bib0135","doi-asserted-by":"crossref","unstructured":"Oparil S, Bakir SE. Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials. Drugs. 2000; 59 Spec No 2:25-37.","DOI":"10.2165\/00003495-200059992-00004"},{"key":"10.1016\/j.cali.2015.01.009_bib0140","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/S0140-6736(96)08359-6","article-title":"Effect of long-acting and short-acting calcium antagonists on cardiovascular outcomes in hypertensive patients","volume":"349","author":"Alderman","year":"1997","journal-title":"Lancet."},{"key":"10.1016\/j.cali.2015.01.009_bib0145","unstructured":"Ministerio de Salud y Protecci\u00f3n Social. Resoluci\u00f3n 5521 de 2013 [consultado Ene 2014]. Disponible en: http:\/\/www.minsalud.gov.co\/sites\/rid\/Lists\/BibliotecaDigital\/RIDE\/DE\/DIJ\/Resoluci%C3%B3n%205521%20de%202013.pdf"},{"key":"10.1016\/j.cali.2015.01.009_bib0150","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1111\/j.1532-5415.1995.tb07393.x","article-title":"Long-term survival and use of antihypertensive medications in older persons","volume":"43","author":"Pahor","year":"1995","journal-title":"J Am Geriatr Soc."},{"key":"10.1016\/j.cali.2015.01.009_bib0155","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1053\/pcad.2000.7010","article-title":"Current status of safety and efficacy of calcium channel blockers in cardiovascular diseases: A critical analysis based on 100 studies","volume":"43","author":"Opie","year":"2000","journal-title":"Prog Cardiovasc Dis."},{"key":"10.1016\/j.cali.2015.01.009_bib0160","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2165\/11586670-000000000-00000","article-title":"The correct administration of antihypertensive drugs according to the principles of clinical pharmacology","volume":"11","author":"Taddei","year":"2011","journal-title":"Am J Cardiovasc Drugs."},{"key":"10.1016\/j.cali.2015.01.009_bib0165","doi-asserted-by":"crossref","first-page":"503821","DOI":"10.1155\/2012\/503821","article-title":"Physicians\u2019 perceptions and adherence to guidelines for the management of hypertension: A national, multicentre, prospective study","volume":"2012","author":"Theodorou","year":"2012","journal-title":"Int J Hypertens."},{"key":"10.1016\/j.cali.2015.01.009_bib0170","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cali.2011.06.004","article-title":"Quality prescribing of long-acting beta-agonists. Results of an intervention in Primary Care","volume":"27","author":"Fern\u00e1ndez Urrusuno","year":"2012","journal-title":"Rev Calid Asist."},{"key":"10.1016\/j.cali.2015.01.009_bib0175","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/jch.12117","article-title":"Therapeutic inertia and measurement inertia in hypertension: A call to action","volume":"15","author":"Germino","year":"2013","journal-title":"J Clin Hypertens (Greenwich)."},{"key":"10.1016\/j.cali.2015.01.009_bib0180","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1001\/jama.2011.490","article-title":"Clinical inertia as a clinical safeguard","volume":"305","author":"Giugliano","year":"2011","journal-title":"JAMA."},{"key":"10.1016\/j.cali.2015.01.009_bib0185","first-page":"80","article-title":"Patrones de prescripci\u00f3n de hormonas tiroideas en una poblaci\u00f3n colombiana","volume":"36","author":"Machado-Alba","year":"2014","journal-title":"Rev Panam de Salud P\u00fablica."},{"key":"10.1016\/j.cali.2015.01.009_bib0190","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1111\/j.1365-2125.2012.04248.x","article-title":"Pharmacoepidemiology","volume":"73","author":"Evans","year":"2012","journal-title":"Br J Clin Pharmacol."}],"container-title":["Revista de Calidad Asistencial"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1134282X15000160?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1134282X15000160?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,24]],"date-time":"2018-09-24T14:23:42Z","timestamp":1537799022000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1134282X15000160"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S1134282X15000160"],"URL":"https:\/\/doi.org\/10.1016\/j.cali.2015.01.009","relation":{},"ISSN":["1134-282X"],"issn-type":[{"value":"1134-282X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Calidad de la prescripci\u00f3n de verapamilo de liberaci\u00f3n convencional en pacientes con hipertensi\u00f3n arterial","name":"articletitle","label":"Article Title"},{"value":"Revista de Calidad Asistencial","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cali.2015.01.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 SECA. Published by Elsevier Espa\u00f1a, S.L. All rights reserved.","name":"copyright","label":"Copyright"}]}}